Barclays
SONM icon

Barclays’s DNA X Inc SONM Stock Holding History

Barclays’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6
Closed -$122 – 5714
2025
Q2 		$122 Buy
+6
New +$148 ﹤0.01% 5101
2024
Q4 		– Sell
-1
Closed -$26 – 5463
2024
Q3 		$26 Buy
+1
New +$63 ﹤0.01% 5227
2020
Q3 		– Sell
-2
Closed -$2K – 5550
2020
Q2 		$2K Hold
2
– – ﹤0.01% 5453
2020
Q1 		$2K Sell
2
-4
-67% -$19.2K ﹤0.01% 6038
2019
Q4 		$36K Buy
6
+5
+500% +$24.7K ﹤0.01% 5838
2019
Q3 		$5K Hold
1
– – ﹤0.01% 6452
2019
Q2 		$30K Buy
+1
New +$25.4K ﹤0.01% 6305

Other funds holding SONM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

Barclays's SONM Position: Q3 2025 in Review

Barclays sold out of DNA X Inc (SONM) in Q3 2025, closing a stake of 6 shares — an estimated $122 sold.

Barclays first reported a position in SONM in Q2 2019 and held it in 7 quarters. The position peaked at $36K in Q4 2019. 12 funds tracked by Wall St. Rank hold SONM as of Q3 2025.

  • Barclays reported no remaining DNA X Inc position as of Q3 2025 after selling out during the quarter.
  • Barclays sold 6 DNA X Inc shares in Q3 2025, an estimated $122.
  • Barclays first reported a position in DNA X Inc in Q2 2019 and held it in 7 quarters.
  • Barclays's DNA X Inc position peaked at $36K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.